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ABSTRACT: Titanium implants in orthopedic applications can fail due to infection and 
impaired integration into the host. Most research efforts that facilitate osseointegration of the 
implant have not considered infection and vice versa. Moreover, most infection control 
measures involve the use of conventional antibiotics which contributes to the global epidemic 
of antimicrobial resistance. Nitric oxide (NO) is a promising alternative to antibiotics and 
whilst researchers have investigated NO releasing coatings, few reports on the 
function/robustness or the mechanism of NO release. Our comprehensive mechanistic study 
has allowed us to design, characterize and optimize NO releasing coatings to achieve maximum 
antimicrobial efficacy towards bacteria with minimum cytotoxicity to human primary 
osteoblasts in vitro.  As the antibiotic era is coming to an end and the future of infection control 
continues to demand new alternatives, the coatings described herein represent a promising 
therapeutic strategy for use in orthopedic surgeries.  




Orthopedic implants made from titanium are used extensively given their excellent 
mechanical properties, corrosion resistance and lack of allergenic or immunogenic response.1-
3 However, there are two major causes of implant failure: infections and poor tissue 
integration. The reported rates of these failures differ based on the study, with approximately 
20% due to infection and 18% due to poor integration.4-5 Much research in this field has 
focused on developing coatings to prevent bacterial colonization while ignoring integration of 
the implant or vice versa, promoting osseointegration, while ignoring the infection issue. To 
achieve longevity of the implants, both of these modalities must be considered 
simultaneously.  
Implant-associated infections represent a serious complication as once bacteria colonize the 
surface, they form biofilms, which are more difficult to treat, requiring up to a 1000-fold 
increase in the antimicrobial dose.6-7 Once an infection takes place on a titanium implant, 
repeated revision surgeries are often required and can lead to poor implant integration, bone 
loss and soft tissue defects.8-9 Orthopedic implant infections are caused most often caused by 
Staphylococcus species (S. aureus and S. epidermidis) or  Pseudomonas aeruginosa which 
can be acquired during surgery or subsequently through a hematogenous route.10-11 Moreover, 
implants that are transmucosal and percutaneous (e.g. dental and external fixation pins) are 
more susceptible to infection as opportunistic bacteria that reside on the skin mucosa can 
colonize the peri-implant soft tissue which can lead to a peri-implant bone infection.12-13 
Localized delivery of antibiotics via a coating layer on the implant is seen as a promising 
strategy to prevent infections and subsequent failure of the implant. However, given the rise 
in the global epidemic of antimicrobial resistance, much focus has changed to the 
development of alternative antimicrobials such as silver 14-15 zinc ions,14 bioactive 
antibodies,16 antimicrobial peptides17-18 and nitric oxide19-20 which have a low tendency to 
developing multi drug resistant bacteria.  
Nitric oxide (NO) is a potent broad spectrum antimicrobial and part of the body’s defense 
mechanism that is activated by inflammatory cells (neutrophils and macrophages) which are 
responding to invading pathogens such as bacteria, protozoa and fungi.21-22 The antimicrobial 
activity of NO is attributed to the reactive nitrogen oxide species (RNOS) that are produced 
through the spontaneous reaction of NO with oxygen or superoxide that cause damage to 
bacterial DNA, proteins and lipid membranes.23-24 The formation of these RNOS become 
significant or antimicrobial when the concentration of NO is >1μM.23  Given that there are 
several mechanistic pathways for NO to inactivate bacteria, studies have shown that there is a 
low tendency for bacteria to develop resistance to this antimicrobial.25-26 Furthermore as 
eukaryotic cells have evolved mechanisms that are capable of scavenging these RNOS, it is 
thought that NO will exhibit a low toxicity on the host.21  
Although NO is clearly identified as a potent antimicrobial, its clinical utility is challenging 
as NO is a highly reactive gas with a short half-life27. As such, there has been much research 
focused on the development of NO donors such as N-diazeniumdiolates, S-nitrosothiols, 
organic nitrates, metal nitrosyls which can store and release NO for more prolonged periods 
of time under requisite conditions.28-30 The most commonly reported N-diazeniumdiolates 
(containing the [N(O-)N=O]) are adducts formed from a NO dimer with a secondary amine 
nucleophile.27, 29 These N-diazeniumdiolates can spontaneously decompose with tunable half-
lives dependent on the structure of the nucleophile (amine), pH and temperature.29 As 
secondary amine diazeniumdiolates are formed much easier, much work has focused on these 
rather than primary amine diazeniumdiolates.31-34 Although many of these studies have 
investigated how NO can be released for biomaterial/medical device applications, there is a 
paucity of information regarding the mechanism of release and the robustness of the coatings. 
For example, Ho and coworkers focused on the feasibility of using plasma polymerization to 
coat polymer surfaces with allylamine and diallylamine coatings, followed by the 
incorporation of diazeniumdiolates.34  In this study, although they have looked at primary and 
secondary diazeniumdiolates and have obtained a higher NO payload with the secondary 
diazeniumdiolate,34 they have not evaluated the stability or shelf-life of the coatings or 
investigated the potential cytotoxicity of the materials. Moreover, the underlying coatings are 
not optimized to promote osseointegration.  
In previous work, Curran et al have established that amino terminated silanes (as opposed to 
methyl, hydroxyl, or thiol) can control cell responses, resulting in the formation of high 
quality de novo tissue.35-36  These comprehensive investigations were performed with a 
variety of silanized glass surfaces to understand the effect of silane chain length on associated 
osteoinductive properties of the surface.35 Within this work, only the longer chain silanes 
containing pendant amino groups resulted in the formation of an apatite‐like layer on the 
surface that induced a significantly enhanced osteoinductive response across the entirety of 
the surface.   
Based on the work of Curran and coworkers, we have chosen the amino-terminated silane 
(11‐Aminoundecyltriethoxysilane, AUTES) with the most consistent and homogeneous 
osteoinductive property and used this to tether NO. The hypothesis here is as the underlying 
surface is known to be osteoinductive, once the NO is released and any potential infection 
during implantation is averted, osseointegration can take place. Within this preliminary study 
we investigate the effect of NO on the initial and prolonged (after 7 days) viable adhesion of 
primary human osteoblasts to the modified surfaces.  However, since primary 
diazeniumdiolates are not as well studied and do not release as much NO37, we wanted to test 
another potentially osseointegrative promoting silane containing a secondary amine in order 
to investigate the effects of primary vs secondary amines in terms of antimicrobial efficacy.  
In this study, we report on the functionalization of Ti with two different aminosilanes and the 
subsequent tethering of diazeniumdiolates onto the silanes. We have carried out a 
comprehensive mechanistic study of NO releasing coatings developed to understand the 
kinetics and payload of release as a function of the stability of the silane, the nature of the 
amino functional group and pH of release. This mechanistic understanding will allow fine 
tuning of the antimicrobial efficacy to prevent infection at 6 hrs (time frame for initial 
bacterial adhesion vs. mammalian cell adhesion) in the so called “race to the surface”. The 
antimicrobial efficacy against Staphylococcus aureus and Pseudomonas aeruginosa have 
been studied at 6 and 24 hrs and cytocompatibility of the surfaces with primary human 
osteoblast cells was investigated in order to improve the integration of implants with bone.  
 
 
2. MATERIALS AND METHODS  
2.1 Experimental Materials. Ti rods (ø 6.4mm, 99.7% metal basis) were purchased from 
Alfa Aesar and cut into pieces 1.5 mm in thickness. 6-Aminohexyl-3-aminopropyl 
trimethoxysilane (AHAP3, 95%), 11-Aminoundecyltriethoxysilane (AUTES, > 95%), n-
Decyltrimethoxysilane (DTMS, 97%) were purchased from Fluoro Chem. Ethanol, acetic 
acid (HAc), sodium acetate (NaAc), Luria Bertani Broth (LB Broth), LB agar, Dulbecco’s 
Modified Eagle Medium (DMEM), fetal bovine serum (FBS), Penicillin-Streptomycin, 
Trypsin-EDTA solution, formaldehyde solution and Triton™ X-100 were purchased from 
Sigma-Aldrich. 4′,6-diamidino-2-phenylindole (DAPI) staining mounting gel and ActinGreen 
™ 488 reagent kit were obtained from Thermo Fisher Scientific.  
2.2 Titanium Pre-Treatment. Ti discs were polished with SiC sand paper (1200-grit) and 
then washed with ethanol and DI water for 15 mins each. Washed Ti discs were then air dried 
at room temperature and stored in a desiccator until use. 
2.3 Silanization and Diazeniumdiolate-Functionalization. Pristine polished Ti discs were 
immersed in 10 wt % silane solutions (Amino-silanes: AHAP3, AUTES and Control alkyl 
silane: DTMS) prepared in ethanol and shaken on a gyro-rocker (SSL3, Stuart) at 70 rpm for 
4 hrs. Samples were then washed with ethanol 3 times to remove unreacted silane and cured 
in an oven at 80° C for 4 hrs. At the end of this time, samples were then stored in a desiccator 
until diazeniumdiolate functionalization. Silanized samples are referred to as AHAP3, 
AUTES and DTMS, respectively. Silanized Ti discs were functionalized with 
diazeniumdiolates in an in-house built stainless steel NO reactor as previously reported.38 
Briefly, the reactor chamber was purged with 6 bar argon (BOC, Guildford, UK) for 5 mins 
(3 x) and 10 mins (3 x) to remove atmospheric oxygen and water. Then nitric oxide (NO) 
(BOC, Guildford, UK) was introduced into the reactor at 5 bar for 3 days. At the end of this 
time, residual NO was removed by flushing the chamber with 6 bar argon for 5 mins (2 x) 
and 10 mins (2 x). Diazeniumdiolate functionalized Ti samples were then stored at -20°C 
until use. Diazeniumdiolate functionalized samples are referred to as Ti/NO, AHAP3/NO, 
AUTES/NO and DTMS/NO, respectively. It should be noted that Titanium samples will have 
an oxide layer on the surface and most likely exist as TiOx. Moreover as Ti and DTMS do 
not possess any amine functionality, there is no possibility of forming N-diazeniumdiolates, 
and as such these are control samples. The nomenclature is kept as Ti/NO and DTMS/NO for 
consistency and ease of readership.   
2.4 Characterization. 2.4.1 Contact Angle Analysis. Static contact angles (Attension 
ThetaLite, Biolin Scientific, Västra Frölunda, Sweden) were used to determine the changes in 
surface wettability of all samples. The sessile drop method was used and contact angle 
measurement images were taken using OneAttension software (Biolin Scientific, Västra 
Frölunda, Sweden). Three random spots were performed per sample type (n=3) and mean 
values ± standard deviations of the samples were recorded and repeated twice.  
2.4.2 Atomic Force Microscopy Analysis. Atomic force microscopy (AFM) was used to 
observe the surface topography changes of silanized samples (Bruker Multimode 8 fitted with 
a NanoScope V controller; Bruker, Billerica, MA, USA). Samples were imaged in air in 
ScanAsyst mode using a silicon RTESPA-525 tip, operating at a scan rate of 0.9 Hz. At least 
three replicate regions including the centre and edge of 10 x 10 µm2 of each sample were 
imaged and repeated twice. The mean roughness (Ra) and root mean square roughness (Rq) 
were measured using NanoScope Analysis 1.7 software. 
2.4.3 X-ray Photoelectron Spectroscopy. Functionalized surfaces were analyzed by X-ray 
photoelectron spectroscopy (XPS) on an Axis-Supra instrument from Kratos Analytical with 
monochromatic Al Kα radiation (225W). Survey scan spectra were recorded at a pass energy 
of 160 eV and a 1 eV step size. High resolution scans were acquired at a pass energy of 20 
eV and a 0.1 eV step size. The XPS spectra were recorded in normal emission. Three random 
areas on each sample were analyzed and the results are reported as the mean average atomic 
percentage concentration (at. %) ± standard deviations. Spectra were processed using 
CasaXPS 2.3.19PR1.0 software (Casa software, UK) and charge calibrated to C 1s at 284.8 
eV. Spectra were curve fitted with a mixed Gaussian-Lorentzian function after Shirley 
background subtraction.  
2.4.4 NO Release Measurement. Nitric oxide release from samples was measured using a 
Sievers 280i Chemiluminescence Nitric Oxide Analyzer (NOA280i, GE, USA). The 
instrument measures nitric oxide based on a gas-phase chemiluminescent reaction between 
nitric oxide and ozone: 
NO + O3 → NO2
* + O2  
NO2
* 
→ NO2 + hv  
Emission from electronically excited nitrogen dioxide is in the red and near-infrared region of 
the spectrum, and is detected by a thermoelectrically cooled, red-sensitive photomultiplier 
tube. Before measurement, calibration was carried out by using zero air filter and 89.2 ppm 
NO (g) (balance nitrogen). The diazeniumdiolate functionalized samples (6.4 mm diameter, 
1.5 mm thick) were immersed in 5 ml of acetic acid buffer (pH 4) or phosphate buffered 
saline (PBS; pH 7.4 and pH 8.5) at room temperature in a three-neck round bottom flask. 
Nitrogen gas was continuously sparged though the buffer at a flow rate of 70 mL / min 
measured with a gas flow meter. An additional nitrogen flow of 130 mL / min passed through 
the headspace of the vessel to the bubbled solution phase, according to the NOA manual. 
While the standard NOA restrictor provides a flow rate of 150 ml / min. A vacuum pump 
connected with the NOA is used to draw the mixed gases in to the reaction cell and maintains 
the pressure of the reaction cell. Nitric oxide release was measured at an interval of 1 s over 
more than 20 hrs. Each sample was measured in triplicate. 
2.5 Biofilm Assay and Morphology Analysis. Staphylococcus aureus (S. aureus) ATCC 
25923 and Pseudomonas aeruginosa (P. aeruginosa) PA01 were used to evaluate the biofilm 
inhibition efficiency of the nitric oxide releasing surfaces. Overnight cultured bacteria were 
diluted to 106 CFU/mL according to McFarland Standards in LB broth. Samples were placed 
in a 48 well-plate and 500 µL diluted bacterial solution was added to each well before 
incubating at 37 °C to allow biofilm formation. After incubation, samples were gently 
washed with PBS once to remove any unattached planktonic bacteria and then 1 mL of fresh 
LB broth was used to remove and re-suspend the biofilms. The bacterial CFU was 
determined after serial dilution of the bacterial suspension using the Miles and Misra method 
on LB agar plates.39  
After incubation with bacteria, the samples were fixed with 2.5% glutaraldehyde solution in 
sterile PBS for 4 hrs at 4 °C, then dehydrated with increasing concentrations of ethanol (30, 
50, 75, 90, 95, and 100 v/v %) for 10 min. After drying the samples were coated with gold 
(Q150T ES sputter coater; Quorum, East Sussex, UK) before SEM imaging (JSM 7001F 
FEGSEM; JEOL, Tokyo, Japan).  
2.6 In Vitro Cell Culture and Immunocytochemistry Analysis. Primary human osteoblast 
cells were expanded and maintained in vitro in DMEM media supplemented with 10% FBS 
and 1% penicillin-streptomycin in a humidified atmosphere of 5% CO2 at 37 °C and used 
between passages 5 and 10. Upon confluence cells were rinsed in sterile PBS and incubated 
with trypsin-EDTA for 3 minutes at 37 °C to remove the cells from tissue culture polystyrene 
(TCPS) and retain in solution, diluted to 1 x 105 cells/ml using the afore mentioned culture 
medium. Samples were incubated with 1 ml of cell suspension per well in 24-well culture 
plates. The media was replaced with fresh cell culture media every 3 days.  
At day 7 of culture, cells were prepared for staining using the following protocols. Medium 
was removed from the wells and samples were rinsed with sterile PBS for 5 minutes at 37 °C. 
Cells were then fixed using 4% formaldehyde for 15 min at room temperature, followed by 
rinsing with PBS. Then cells were permeabilized with 0.5% Triton® X-100 for a further 15 
min at room temperature. After washing 3 times with PBS, cells were incubated with diluted 
Oregon Green PhallodinTM 488 kit (5µg/ml) for 30 min at 4°C followed by further rinsing 
with PBS prior to mounting with DAPI staining mounting medium (Vector, UK). Cell 
morphology images were obtained by confocal laser scanning microscopy (LSM 510, Zeiss, 
Germany). 6 images were taken per samples and representative images are shown. Images 
were processed using ImageJ 1.48 software.  
2.7 Statistical Analysis. One-way analysis of variance (ANOVA) was used to analyze the 
differences among various treatment samples. The Student-Newman-Keuls (SNK) method 
was carried out to determine significance between treatment types. A value of p < 0.05 was 
taken as being statistically significant.  
 
3. RESULTS AND DISCUSSION 
3.1 Synthesis of N-Diazeniumdiolate-Functionalized Titanium. The diazeniumdiolate 
functionalized Ti surfaces were synthesized via a two-step method illustrated in Figure 1. 
Polished Ti surfaces were functionalized with silanes with or without primary and secondary 
amines; 6-Aminohexyl-3-aminopropyl trimethoxysilane (AHAP3): 1 primary amine and 1 
secondary amine, 11-Aminoundecyltriethoxysilane (AUTES): 1 primary amine and n-
Decyltrimethoxysilane (DTMS): no amine. The silane-modified Ti substrates were then 
exposed to high pressures of NO (5 bar) over 72 hrs to allow formation of diazeniumdiolate 
NO donors. 
 
Figure 1. Diazeniumdiolate functionalization of titanium surfaces. 
3.2 Surface Wettability: Static Water Contact Angle. The wettability of the Ti substrates 
before and after functionalization was determined using static contact angles with the results 
shown in Figure 2. Pristine Ti had an average contact angle of 64°. After silanization, the 
contact angles for AHAP3, AUTES and DTMS films on Ti increased to 78, 83 and 101°, 
respectively. The increase in contact angle can be attributed to the presence of hydrophobic 
alkyl silane chains confirming functionalization of the surface. DTMS displayed the most 
hydrophobic character, as there is no electronegative amino group present in the silane 
molecule.  
 
Figure 2. Measurement of contact angle with water drops at room temperature. a) Contact 
angle images of pristine Ti (p_Ti) and silanized p_Ti with AHAP3, AUTES and DTMS. b) 
Measurement of contact angles of p_Ti and silanized p_Ti. Each bar represents mean ± SD 
(n=3). *p < 0.05, relative to the control.  
3.3 Surface Topography: Atomic Force Microscopy. The topography of Ti and 
functionalized Ti surfaces was investigated using AFM (Table 1 and Figure 3). Pristine Ti 
has a roughness of 35.5 ± 0.8 nm (Ra) (Figure 3a) and all of the silanized surfaces showed a 
statistically significant increase in roughness (Figure 3b- d). This is indicative of the 
deposition of multiple layers of silane on the surface. Indeed there is visible aggregation of 
the silane observed on all of the silanized surfaces (Figure 3b-d). The silanized surfaces 
displayed roughness values (Ra) of: AHAP3 (108.1 ± 16.4 nm), AUTES (87.1 ± 8.7 nm) and 
DTMS (64.8 ± 17.4 nm) (also listed in Table 1.).  
 
Table 1. Topography of Silanized Surfaces 
roughness p_Ti AHAP3 AUTES DTMS 
Rq (nm) 46.4 ± 2.1  135.0 ± 26.0 a 109.2 ± 9.1 a 80.9 ± 22.0  
Ra (nm) 35.5 ± 0.8  108.1 ± 16.4 a 87.1 ± 8.7 a 64.8 ± 17.4 a 
a indicates statistical significance (p < 0.05) between the control and silanization surfaces. 
 
 
Figure 3. AFM height mode of silanized surfaces. The cross-sections of 10 × 10 µm2 size 
images are shown at different z-axis maximum heights. a) p_Ti, b) AHAP3, c) AUTES, d) 
DTMS. 
3.4 Surface Chemistry: X-ray Photoelectron Spectroscopy. The surface chemistry of the 
silanized surfaces pre- and post- diazeniumdiolate treatment were analyzed by XPS with the 
resultant at. % shown in Table 2. XPS analysis shows that pristine Ti consists of Ti, C, O and 
N. After silanization with all 3 silanes, the Ti 2p peak decreases with an increase in the C 1s 
peak and introduction of the Si 2p peak, confirming the silanization of the surface. Following 
exposure of the silanized Ti surfaces to NO, the at. % of the C 1s peak decreases with a 
concomitant rise in the O 1s and N 1s peaks confirming formation of the N-diazeniumdiolate 




Table 2. Atomic Surface Concentration (at. %) of Pristine Ti Surface, Silanized Surfaces and 
Diazeniumdiolates-Functionalized Surfaces 
sample  C (1s) O (1s) N (1s) Ti (2p) Si (2p) 
p_Ti 28.2±1.4 52.2±0.8 0.6±0.5 18.9±1.1 - 
AHAP3 63.9±5.3 15.2±5.4 9.6±1.4 1.3±2.3 9.9±1.2 
AUTES 75.0±0.3 11.5±0.2 3.7±0.4 - 9.8±0.2 
DTMS 47.9±0.8 34.4±0.5 1.7±0.3 11.7±0.5 4.2±0.3 
Ti/NO 49.3±2.7 39.4±2.2 1.7±0.8 9.5±1.3  - 
AHAP3/NO 57.1±1.2 26.4±1.1 10.3±0.3 0.6±0.5 5.5±0.2 
AUTES/NO 71.5±0.2 17.8±0.2 1.8±0.5 0.1±0.1 8.8±0.4 
DTMS/NO 62.2±3.5 25.8±4.9 0.8±0.4 4.1±2.0 7.0±1.4 
 
The silanization and functionalization with diazeniumdiolate can also be corroborated by 
analyzing the curve fitted high resolution N 1s spectra shown in Figure 4 (with the associated 
quantitative information given in Table S1 of the Supplementary Information). The presence 
of nitrogen on pristine Ti (Figure 4a) is due to the nitrogen contamination of the raw material 
(N: 0.02% in Ti rod, data from certificate of analysis document, Alfa Aesar). Following 
silanization with the aminosilanes, AHAP3 and AUTES, two additional states of nitrogen 
observed, with binding energies at ~400.5 eV (N-H) and ~401.6 eV (N+) (Figure 4c and 4e). 
After exposure to high pressures of NO, diazeniumdiolate formation was confirmed via the 
presence of the new peaks observed, indicative of N-H (400.5 eV), N-O (402.3 eV), and NO4
- 
(~407 eV) bonds. Moreover, the presence of the N-O bond is observed with a decrease in the 
N-H bond, confirming the nucleophilic attack of the amine group on the NO dimer forming 
the diazeniumdiolate functional group. Interestingly, DTMS does not have any pendant 
amino groups but after exposure to NO gas, the N 1s envelope shows the presence of N-O 
peak (28%). This is probably due to some physisorbed NO on the surfaces that have been 
converted to nitrates and nitrites. 
 
Figure 4. High-resolution N 1s spectra of (a) p_Ti, (b) Ti/NO, (c) AHAP3, (d) AHAP3/NO, 
(e) AUTES, (f) AUTES/NO, (g) DTMS and (h) DTMS/NO. The peak at ~401.6 eV represent 
–N+ and the N-O bond shows a bonding energy at ~402.3 eV, shows successful formation of 
diazeniumdiolates. 
 
3.5 NO Release from Diazeniumdiolate-Functionalized Surfaces. In order to understand 
the effects of pH on NO release, the NO-payload from the diazeniumdiolate-modified 
surfaces was determined using a chemiluminescence nitric oxide analyzer in acetate and PBS 
buffers at pH 4, 7.4 and 8.5. The NO release profiles of Ti/NO, Ti-AHAP3/NO, Ti-
AUTES/NO and Ti-DTMS/NO are shown in Figure 5. The total concentration of NO after 1 
hr (t[NO]), half-life of NO release (t1/2), maximum instantaneous NO release concentration 
([NO]m), time required to reach [NO]m (tm) and NO release duration (td) from each surface 
were determined and the values are summarized in Table 3. The NO payload and release 
kinetics were dependent upon the number and class of amines in the silane, the pH of the 
release buffer and if a monolayer or multilayer of silane was present on the surface. 
AHAP3/NO: At pH 4, AHAP3/NO surfaces released NO at a maximum instantaneous NO 
release concentration of 1.8 µM·s-1 with 1005.4 µM NO being released in a burst during the 
first hour. At pH 7.4, the concentration of NO released was less than that observed at pH 4, 
with 676.8 µM of NO released during the first hour. At pH 8.5, the AHAP3/NO surface 
released a NO concentration of 330.5 µM during the first hour. 
AUTES/NO: At pH 4, AUTES/NO surfaces released a maximum instantaneous NO release 
concentration of 5.6 µM·s-1 and 1883.6 µM NO was released in a burst during the first hour. 
At pH 7.4, the concentration of NO released was less than that observed at pH 4. 476.2 µM of 
NO was released during the first hour. At pH 8.5, the AUTES/NO surface released 133.7 µM 
during the first hour.  
DTMS/NO: At pH 4, DTMS/NO surface, released 231.1 µM of NO with a maximum 
instantaneous NO release concentration of 0.4 µM·s-1. At pH 7.4, the concentration of NO 
released was less than that observed at pH 4. The final concentration of NO released was 26 
µM during the first hour. At pH 8.5, the DTMS/NO surface released no measurable NO. 
DTMS/NO has no amine in its backbone and therefore cannot form an N-diazeniumdiolate.  
3.6 Mechanism of NO Release. The mechanism of NO release is dependent on three factors 
as described below: pKa of the amine, class of amine (primary vs secondary) and quality of 
the silane layer formed on the surface. 
pKa: The NO release from diazeniumdiolate occurs via protonation of the amine precursor 
and the release kinetics are dependent upon the pKa of the amine. As such, the higher the 
pKa the easier the protonation and the faster the release at physiological conditions. The rate 
of release of NO can also be increased by other factors such as the presence of neighboring 
amines which can act as a proton source40 and an increase in temperature.41 This is indeed 
what was experimentally observed for the AHAP3/NO and the AUTES/NO surfaces; at pH 4 
these surfaces showed a burst release of NO.  
Class of amine: Keefer and co-workers have demonstrated that primary 
amine diazeniumdiolates decompose to HNO and NO with the product ratio dependent on the 
pH and the basicity of the nitroso oxygen formed.33 In contrast, secondary amines only 
undergo decomposition based on pH mediated protonation to produce exclusively NO.33 
Keefer has shown that primary amine diazeniumdiolates decompose: (a) exclusively to NO at 
pH 5; (b) to a mixture of HNO and NO at pH 5-8, and (c) exclusively to HNO above pH 8. In 
our work, AHAP3/NO has the potential to form one secondary and one primary amine 
diazeniumdiolate and AUTES/NO has the potential to form only a primary amine 
diazeniumdiolate. Therefore, based on Keefer’s mechanism,33 AHAP3/NO and AUTES/NO 
will release the highest concentration of NO at pH 4 as both the primary and secondary 
amines exclusively decompose to NO. The concentration of NO will then decrease as the pH 
of the release buffer increases due to the presence of primary amines and subsequent 
decomposition to HNO. Despite the AHAP3 releasing lower amounts of NO at pH 4 (1005.4 
µM) than the AUTES (1883 µM), the release concentration exceeds the concentration 
released by AUTES at pH 7.4 due to the presence of a secondary amine in AHAP3.  
Number of amines/Quality of silane layer: AHAP3 has one secondary amine and one primary 
amine and therefore the potential to form of two diazeniumdiolates and have double the 
payload of NO at pH 4. In solution, this is indeed what is observed, where AHAP3/NO (10 
µl/5 ml PBS) shows a maximum NO release of 1993.3 µM·s-1, in comparison with AUTES 
(Figure S1). However, we observed the opposite when the silanes were immobilized on the 
surface, with AHAP3/NO and AUTES/NO having NO payloads of 1005.4 µM and 1883.6 
µM within the first hour. The lower payload observed here is due to the quality of the silane 
monolayer formed.  
A more cohesive silane coverage on Ti surfaces should yield a higher NO payload. AUTES 
forms a monolayer on the surface through hydrolysis of an ethoxy leaving group to generate 
silanol containing species that readily condenses on the surface. The faster the hydrolysis of 
the silane, the faster the condensation and the increase in the self-condensation/aggregation 
reactions (a less cohesive monolayer is formed on the surface). The rate of hydrolysis of the 
alkoxy groups are dependent on their size (CH3O>C2H5O>t-C4H9O), meaning that a 
methoxysilane hydrolyses 6 - 10x quicker than an ethoxysilane.42-45 Therefore, as 
ethoxysilanes hydrolyze slower than methoxysilanes, they will form more cohesive 
monolayers on the surface. In our work, AHAP3 is a methoxysilane and AUTES is an 
ethoxysilane. This explains why AHAP3/NO on the surface has a lower NO payload when on 






Figure 5. Chemiluminescence NO release profiles of (a) overall 20 hrs and the insert is 
rescaling of the first 0.4 hr at pH 4, (b) rescale detailing over 20 hrs at pH 4, (c) overall 20 hrs 
and the insert is rescaling of the first 0.2 hr at pH 7.4, (d) rescale detailing over 20 hrs at pH 
7.4 and (e) overall 20 hrs at pH = 8.5 buffers at room temperature. The inserts have the same 




Table 3. NO release properties for diazeniumdiolate-functionalized surfaces prepared by using 
silane with different amine groups in pH 4, 7.4 and 8.5 
 Silane 
precursor 
Number of amine t[NO]  t[NO]  t1/2 [NO]m tm td 
 primary secondary (µM) (µM·cm-2) (min) (µM·s-1·cm-2) (min) (h) 
 AHAP3 1 1 1005.4 3122.4 34.2 5.6 7.4 18.1 
pH 4 AUTES 1 0 1883.6 5849.7 52.8 17.4 3.2 3.2 
 DTMS 0 0 231.1 717.7 8.0 1.3 4.5 0.8 
 AHAP3 1 1 676.8 2101.9 16.3 3.1 2.7 16.5 
pH 7.4 AUTES 1 0 476.2 1478.9 2.4 10.2 1.5 1.5 
 DTMS 0 0 26.0 80.7 0.2 0.3 2.1 0.7 
 AHAP3 1 1 330.5 1026.4 183.9 0.9 5.6 20+ 
pH 8.5 AUTES 1 0 133.7 415.2 159.8 0.3 5.3 10 
 DTMS 0 0 - - - - - - 
 
3.7 Antimicrobial Analysis. A Gram-positive S. aureus, and Gram-negative P. aeruginosa, 
two relevant pathogens for orthopedic infections,46 were selected to measure the 
antimicrobial efficacy of NO releasing samples. The SEM micrographs of S. aureus and P. 
aeruginosa cultured for 6 hrs on Ti, AHAP3, AUTES and DTMS samples with/without NO 
release are shown in Figure 6. Bacterial clusters and biofilms can clearly be observed on 
pristine Ti (as shown in Figure 6a (i)), and all non-NO releasing silanized surfaces (AHAP3, 
AUTES, and DTMS, Figures 6b-d (i) respectively) demonstrating that these surfaces do not 
exhibit antimicrobial activity. Tethering of the diazeniumdiolate to the aminosilanized 
surfaces AHAP3/NO (Figure 6b (ii, iv)) and AUTES/NO (Figure 6c (ii, iv)) demonstrate a 
reduction in the S. aureus and P. aeruginosa adhered to the surface, in comparison to Ti/NO 
(Figure 6a (ii, iv) and DTMS/NO (Figure 6d (ii,iv)). This is in agreement with the results 
presented in Figure 5, which demonstrates that the surfaces that release the highest payload of 
NO exhibit the most antimicrobial activity.  
The prevention of biofilm formation on all surfaces at 6 and 24 hrs was determined by using 
a biofilm CFU assay and the results are presented in Figure 6e for S. aureus. The AHAP3/NO 
surface showed a reduction in the number of adhered S. aureus from 0.8×108 CFU/ml to ~106 
CFU/ml at 6 hrs which corresponds to a 1.5 log reduction (Figure 6e). Likewise, the 
AUTES/NO surface showed a reduction in the number of adhered S. aureus from 4.1×107 
CFU/ml to ~106 CFU/ml at 6 hrs which corresponds to a 0.8 log reduction (Figure 6e). At 24 
hrs, the reduction in the adhered bacteria is approx. 1.5 log for AHAP3 to AHAP3/NO and 
0.8 log for AUTES to AUTES/NO. This difference in antimicrobial activity is in agreement 
with the results presented in Table 3 which show that the AHAP3/NO surface has a higher 
payload of NO at pH 7.4 (676.8 µM) vs AUTES/NO (476.2 µM). The surface of Ti/NO and 
DTMS/NO did not show any reduction in the adhered bacteria. A salient point here is that the 
NO release profiles were carried out in 5 mL of measurement buffer, whilst, the antimicrobial 
experiments were carried out in 500 μL of broth. Hence the bacteria in these experiments are 
exposed to 10x the payload observed in the NO release profiles and within the reported range 
need for antimicrobial activity by Friedman and coworkers23.  
The prevention of biofilm formation on all surfaces at 6 and 24 hrs was determined by using 
a biofilm CFU assay and the results are presented in Figure 6f for P. aeruginosa. The 
AHAP3/NO surface showed a reduction in the number of adhered P. aeruginosa from ~105 
CFU / ml to 1.6×104 CFU / ml at 6 hrs which corresponds to a 0.8 log reduction (Figure 6f). 
Likewise, the AUTES/NO surface showed a reduction in the number of adhered P. 
aeruginosa from 1.6×105 CFU / ml to 3×104 CFU / ml at 6 hrs which corresponds to a 0.8 log 
reduction (Figure 6f). At 24 hrs, the reduction in the adhered bacteria is approx. 0.3 log for 
AHAP3 to AHAP3/NO and there was no significant reduction for AUTES to AUTES/NO. 
This difference in antimicrobial activity is in agreement with the results presented in Table 3 
which show that the AHAP3/NO surface has a higher payload of NO at pH 7.4 (676.8 µM) vs 
AUTES/NO (476.2 µM). The surface of Ti/NO and DTMS/NO did not show any reduction in 
the adhered bacteria. As mentioned above, as the antimicrobial experiments are carried out in 
only 500 µl of broth, the bacteria are exposed to 10x the payload observed in the NO release 




Figure 6. SEM images of (a(i) to d(ii)) S. aureus and (a(iii) to d(iv)) P. aeruginosa after 6hrs 
growth on a(i and iii) Ti and (ii and iv)Ti/NO, b(i and iii) AHAP3 and (ii and iv)AHAP3/NO, 
c(i and iii) AUTES and (ii and iv)AUTES/NO, d(i and iii) DTMS and (ii and iv)DTMS/NO. 
Inserts in a-d are enlargements of the figures. The scale bar represents 10 µm and 1 µm in 
insets. (e) S. aureus and (f) P. aeruginosa colonies formation on the surfaces after 6 hrs and 
24 hrs incubation. * p < 0.05 and ** p < 0.01 from control, and # p < 0.05 and ## p < 0.01 
from corresponding silane. 
 
3.8 Cell Morphology. The morphology of human primary osteoblasts was studied on the 
various surfaces at 7 days post seeding using confocal laser scanning microscopy (Figure 7). 
As expected, the osteoblasts present on the control surfaces (pristine Ti (Figure 7a(i)) and 
DTMS (Figure 7d(i)) were well spread with a high contact area, a complex network of actin 
fibers and displayed characteristic cobblestone morphology associated with adherent 
functional osteoblasts. NO treatment of the control surfaces (pristine Ti (Figure 7a(ii)) and 
DTMS (Figure 7d(ii)) did not affect the morphology of the cells. On the AHAP3 (Figure 
7b(i)) and the AUTES (Figure 7c(i)), the osteoblasts had a shrunken morphology, poor actin 
cytoskeletal formation and there were fewer cells. In direct comparison, qualitative analysis 
of the cell response to the AHAP3/NO and AUTES/NO surfaces revealed a more positive 
expression in terms of cell response. Qualitative analysis of these surfaces demonstrated that 
when cells were cultured in contact with AHAP3/NO (Figure 7 bii) cells were well adhered 
and spread with a distinctive formation of stress fibers through the body of the cells. Cells 
cultured in contact with AUTES/NO (Figure 7cii) demonstrated an elevated level of cell 
adhesion and actin formation compared to AHAP3 surfaces, and even showed formation of 
the characteristic cobblestone morphology that is associated with well adhered functional 
osteoblasts and was also apparent on the control surfaces. 
 
 
Figure 7. Fluorescence images of human osteoblasts spreading on a(i) Ti and (ii)Ti/NO, b(i) 
AHAP3 and (ii) AHAP3/NO, c(i) AUTES and (ii) AUTES/NO, d(i) DTMS and (ii) 
DTMS/NO after 7 days incubation. Representative images, n = 6 per group. Scale bar: 100 
µm, F-actin (green) and nucleus (blue).  
 
4. CONCLUSION  
The prevention of bacterial adhesion and biofilm formation whilst promoting osteointegration 
remains a significant medical challenge. We have developed an efficient NO-releasing 
coating on Ti surfaces. A key focus of this study was to understand mechanistically how 
aminosilanes tether to the surface and how the nature of the aminosilane precursor affects the 
resultant NO releasing properties in terms of payload and release kinetics, whilst acting as an 
initiator for adherence and function of osteoblast cells. The ability of the variously modified 
surfaces to prevent biofilm formation was evaluated, with both the AHAP3/NO and 
AUTES/NO surfaces displaying similar antimicrobial efficacy despite having differing 
inherent NO loading capabilities. Of particular interest is that both AHAP3/NO and 
AUTES/NO surfaces were capable of prevention of biofilm formation while not displaying 
cytotoxicity towards human primary osteoblast cells. Experiments are currently underway to 
evaluate the antimicrobial and osteogenic properties of these surfaces in a bacterial and 
mammalian co-culture model. Furthermore, macromolecular coatings that are capable of 
higher NO payloads that result in higher antimicrobial activity are also the subject of ongoing 
investigation.   
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